6 Ways to Elevate Your Machine Translation Strategy

Future-proof your MT strategy for clinical and regulatory content with this guide.

AI Driven

With 2025 well underway, innovators in the global life sciences and pharmaceutical industries continue to question how to maximize efficiencies and reduce complexities in clinical and regulatory content development and localization. As part of the broader technological roadmap, AI and automation remain front and center as key players in taking these workflows to new heights. Here are six approaches to ensure you don’t miss a pivotal step when adapting and applying your process. 

translation_factory

1. Translation Model Customization

The pharmaceutical industry commands precision and optimal quality in all content. MT models should therefore be tailored and regularly updated such that they align with industry-specific terminology and have built-in glossaries that enforce accuracy and consistency across all translated materials. Using translation memories (TMs) and engine customization with company-specific data enables teams to repurpose pre-approved translations to cut down on review cycle times and ensure content uniformity when compared to “off-the-shelf” machine translation models. 

Learn more about how machine translation drives success ›

2. Integration with Clinical & Regulatory Technologies

From a workflow perspective, MT can be integrated directly into additional content repositories, like an eTMF, RIM, web CMS, and more. This generates faster and more secure MT workflows that can be initiated from those same systems where your documents are authored and stored, in a secure “closed loop” ecosystem. In addition, integration with technologies like generative AI and natural language processing can yield more sophisticated language understanding and translation than MT alone. Explore 5 essential use cases for AI automation in regulatory content. 

clinical_practice
contact

3. Increased Use of Multimodal Translation

With continually evolving capabilities and new use cases being identified, MT may extend beyond text to include multimodal elements, such as translating audio, images, graphs, and other visual content commonly found in pharmaceutical documents. This could enhance the overall translation of complex information and provide significant efficiencies in areas like patient recruitment and medical information, which more frequently utilize multi-channel and non-document-based content.

4. Enhanced Post-Editing Automation

Automation of post-editing processes has become more sophisticated, mitigating the need for extensive human intervention post-MT. Generative AI tools embedded within the review module leveraged by post-editors results in more streamlined workflows and rapid delivery of high-quality, fully reviewed translations.

post_editing
Forrester TEI GlobalLink for Life Sciences

5. Compliance Monitoring and Reporting

MT systems have evolved to incorporate multifaceted tools, such as built-in compliance monitoring features, ensuring that translations comply with specific regulatory requirements through automated checks for terminology consistency and language compliance, for example.

Key steps for regulatory submissions ›

6. Real-Time Collaboration Tools

The integration of real-time collaboration tools within MT platforms enhances efficiency and enables global teams to work simultaneously on translation projects. Features like live editing, instant feedback, and collaborative workflows help cut down the time needed to make documents submission-ready.

discussion regulatory

Additional Resources & Expert Perspectives

Fast, Compliant, Centralized Translation in Action: Lessons from AbbVie & Immunovant

Due to high interest following our GlobalLink NEXT panel, we’re welcoming back Stacey Higgins, Associate Director, COA & Digital Implementation Team of AbbVie alongside Tihirah Harris, Sr Manager, Clinical Business Operations of Immunovant to share how and why they moved to a centralized, tech-enabled translation model—enabling faster trial timelines, cost control, and regulator-ready content. We'll also cover what’s ahead on their centralization roadmap, ...

Fast, Compliant, Centralized Translation in Action: Lessons from AbbVie & Immunovant
Blog

How Patients Discover Clinical Trial Websites: The Role of Localization in Search and Trust

Could localization be the key to improving patient recruitment in clinical trials?Recruiting participants for clinical trials is a critical step in bringing new therapies and treatments to market, but despite advances in digital outreach, the industry still faces major...
Webinar

LifeSci Talks COA Series | Modernizing eCOA: Emulators, Backups, and the Future of Reporting

In this tech-forward episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, welcomes Indira Jain-Figueroa, Product Director at Evinova, for a deep dive into the ever-evolving landscape of eCOA development. Covering everything from cross ...
Blog

Rewriting the Rules of Informed Consent Development with AI

How AI and Structured Content Management Are Transforming the ICF ProcessInformed consent forms (ICFs) are essential to clinical trials, serving as the primary vehicle for communicating study information to participants in a clear, ethical, and compliant manner. Given...
White Paper

Could Data Standardizations be the Silver Bullet for Faster Electronic Clinical Outcome Assessment (eCOA) Deployment?

Choosing an electronic clinical outcome assessment (eCOA) provider is a complex process that involves a variety of different aspects including experience, scientific support and knowledge, integration capabilities, scalability, study-specific requirements, and so much more. ...
White Paper

Accelerating Pharma Labeling with Intelligent, Compliant Content

Juggling multilingual labels across varying regions and products? Managing the updates and complying with local health authorities' requirements can be a challenge for global pharmaceutical companies, who are facing increasing pressure to streamline labelling processes and ...
Webinar

Engaging Patient Communities: A Pathway to Clinical Trial Success

In this webinar, expert speakers from MTS Sickle Cell Foundation, Inc, Rare Disease Diversity Coalition, Black Women’s Health Imperative, and Clinical Research Associates, Inc. will focus on the critical role of patient communities in advancing clinical trials. They will ...

Reach out to our team of AI and MT experts to get started today.

How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.